NetworkNewsBreaks – Nabis Holdings Inc. (CSE: NA
Post# of 31
(Total Views: 147)
Posted On: 08/29/2019 3:16:30 PM
NetworkNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) Enters Alternative Cannabis Consumption Space via Strategic Acquisition
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: A2PL), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, recently announced that is has acquired 49% of Cannova Medical Ltd. (http://nnw.fm/F5Ck6). Based in Israel, Cannova is a provider of innovative solutions for cannabis consumption, such as sublingual strips. An article discussing the company reads, “According to Cannova, the use of sublingual strips allows for better control of dosage quantities and an enhanced effect of active compounds. These sublingual strips can be used to achieve an array of goals like pain management, enhanced sleep quality and depression control. . . . As per the terms of agreement between the two entities, Nabis Holdings has purchased 2,260,500 common shares that represent 49% of Cannova, with the option to acquire the remaining 51% interest. Nabis will retain exclusive distribution rights to the Cannova sublingual strips and all of the related technology.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: A2PL), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, recently announced that is has acquired 49% of Cannova Medical Ltd. (http://nnw.fm/F5Ck6). Based in Israel, Cannova is a provider of innovative solutions for cannabis consumption, such as sublingual strips. An article discussing the company reads, “According to Cannova, the use of sublingual strips allows for better control of dosage quantities and an enhanced effect of active compounds. These sublingual strips can be used to achieve an array of goals like pain management, enhanced sleep quality and depression control. . . . As per the terms of agreement between the two entities, Nabis Holdings has purchased 2,260,500 common shares that represent 49% of Cannova, with the option to acquire the remaining 51% interest. Nabis will retain exclusive distribution rights to the Cannova sublingual strips and all of the related technology.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Nabis Holdings Inc. (NABIF) Stock Research Links
Scroll down for more posts ▼